Most businesses now consider green IT to be an important topic. The reasons for this are varied—from cost savings to political correctness to tax breaks. The focus is usually only on deploying energy-efficient servers and equipment, however, and even here the approach is ad hoc. Hardware and computer centers are the first areas that companies associate with Green IT.

Check out the expert article, which outlines the technical possibilities already available today to be both “green” and highly efficient at the same time.

Ursula Drost and Edmund Hain, Managing Directors, Business Consulting Network International

June 8, 2010. The pharmaceutical industry is facing increased pressure amid rising costs for research and development of new drugs and a declining number of new market-ready medications. Many drugs will lose their patent protection in the coming years. In the United States alone, patents for drugs with combined annual revenues of $70 billion will expire in the next few years.

What’s more, the era of blockbuster drugs seems to be drawing to a close, so companies conducting pharmaceutical research will have to amortize the R&D costs of new drugs from a smaller volume of revenue.

The market is getting more and more competitive, with pressure coming not only from generic drug manufacturers but also from new players, especially in Asia.